Home/Vivesto/Robert Maiorana
RM

Robert Maiorana

Acting Chief Financial Officer (CFO)

Vivesto

Vivesto Pipeline

DrugIndicationPhase
CantrixilHematological (Blood) CancersPreclinical
Paccal Vet (Dog)Canine Splenic Hemangiosarcoma post-splenectomyPilot Clinical Trial
Paccal Vet (Cat)Feline Solid TumorsDose-Finding Study
Apealea (Paclical)Platinum-sensitive Ovarian, Peritoneal, Fallopian Tube Cancer (1st relapse)Marketed (EU)